EUCTR2013-000529-30-GB进行中（未招募）1 期
A pilot study to assess efficacy of prolonged-Release oral fampridine on ambulation and visual function in Neuromyelitis Optica - Assessment of fampridine-PR in NMO
Walton Centre Foundation Trust0 个研究点目标入组 20 人开始时间: 2013年10月17日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Inclusion Criteria:
- •Clinically definite NMO or NMO spectrum disorder
- •18-70 years of age
- •Able to complete the Timed 25 foot walk between 8-45 seconds at screening
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •Exclusion Criteria:
- •Pregnancy or breastfeeding
- •History of seizure
- •Renal impairment i.e. raised creatinine levels
- •Onset of NMO exacerbation within 60 days prior to screening (i.e. unstable impairments)
- •Increase in scheduled corticosteroid treatment during the study.
- •Unable to walk 25 feet.
研究者
相似试验
招募中
不适用
Study to verify the effectiveness of Kumagai's Frailty Preventive System (face-to-face and remote frailty prevention exercise) in reducing the cost of nursing care.Frail, sarcopenia, lifestyle-related diseases, depression in the elderly, sleep disorders, cognitive declineJPRN-UMIN000053192Faculty of Medical Science, University of Fukui300
已完成
不适用
Role of diet in controlling HypertensioCTRI/2012/09/002967Mahesh Bhattacharyya Homoeopathic Medical College and Hospital30
进行中（未招募）
不适用
sing GPS trackers in dementia patients to improve quality of lifeQuality of life of people diagnosed with dementia or memory impairment who are at risk of wandering or getting lostMental and Behavioural DisordersUnspecified dementiaISRCTN16242918South West Yorkshire Partnership NHS Foundation Trust45
尚未招募
不适用
Exploring potential benefit of earlier nutritional interventions in adults with upper gastrointestinal cancer: a randomised trialOesophageal cancerCancer - Oesophageal (gullet)Cancer - StomachStomach cancerACTRN12611000005954Mary Anne Silvers50
进行中（未招募）
1 期
A follow-on study in patients who have received gene therapy for Beta-thalassemia in the TIGET-BTHAL study to assess safety and effectiveness of treatment.Beta-thalassemiaMedDRA version: 20.1Level: LLTClassification code 10054660Term: Thalassemia betaSystem Organ Class: 100000004850EUCTR2017-001366-14-ITGLAXOSMITHKLINE RESEARCH AND DEVELOPMENT10